[HTML][HTML] Osteoporosis in patients with chronic kidney diseases: a systemic review
CY Hsu, LR Chen, KH Chen - International journal of molecular sciences, 2020 - mdpi.com
Chronic kidney disease (CKD) is associated with the development of mineral bone disorder
(MBD), osteoporosis, and fragility fractures. Among CKD patients, adynamic bone disease or …
(MBD), osteoporosis, and fragility fractures. Among CKD patients, adynamic bone disease or …
The origins and formation of bone-resorbing osteoclasts
A Elson, A Anuj, M Barnea-Zohar, N Reuven - Bone, 2022 - Elsevier
Osteoclasts (OCLs) are hematopoietic cells whose physiological function is to degrade
bone. OCLs are key players in the processes that determine and maintain the mass, shape …
bone. OCLs are key players in the processes that determine and maintain the mass, shape …
[HTML][HTML] Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer
X Zhang - Cancer communications, 2019 - Springer
Bone metastasis is the leading cause of death in prostate cancer patients, for which there is
currently no effective treatment. Since the bone microenvironment plays an important role in …
currently no effective treatment. Since the bone microenvironment plays an important role in …
[HTML][HTML] Identification of an IL-1 receptor mutation driving autoinflammation directs IL-1-targeted drug design
Summary The interleukin 1 (IL-1) pathway signals through IL-1 receptor type 1 (IL-1R1) and
emerges as a central mediator for systemic inflammation. Aberrant IL-1 signaling leads to a …
emerges as a central mediator for systemic inflammation. Aberrant IL-1 signaling leads to a …
[HTML][HTML] Medical treatment for osteoporosis: from molecular to clinical opinions
LR Chen, NY Ko, KH Chen - International journal of molecular sciences, 2019 - mdpi.com
Osteoporosis is a major concern all over the world. With aging, a gradual loss of bone mass
results in osteopenia and osteoporosis. Heritable factors account for 60–80% of optimal …
results in osteopenia and osteoporosis. Heritable factors account for 60–80% of optimal …
[HTML][HTML] Biological and clinical aspects of metastatic spinal tumors
J Litak, W Czyżewski, M Szymoniuk, L Sakwa… - Cancers, 2022 - mdpi.com
Simple Summary Spine metastases are a common life-threatening complication of
advanced-stage malignancies and often result in poor prognosis. Symptomatic spine …
advanced-stage malignancies and often result in poor prognosis. Symptomatic spine …
[HTML][HTML] When the damage is done: injury and repair in thymus function
S Kinsella, JA Dudakov - Frontiers in immunology, 2020 - frontiersin.org
Even though the thymus is exquisitely sensitive to acute insults like infection, shock, or
common cancer therapies such as cytoreductive chemo-or radiation-therapy, it also has a …
common cancer therapies such as cytoreductive chemo-or radiation-therapy, it also has a …
Epigenetic quantification of immunosenescent CD8+ TEMRA cells in human blood
Age‐related changes in human T‐cell populations are important contributors to
immunosenescence. In particular, terminally differentiated CD8+ effector memory CD45RA+ …
immunosenescence. In particular, terminally differentiated CD8+ effector memory CD45RA+ …
Anti-inflammatory natural products as potential therapeutic agents of rheumatoid arthritis: A systematic review
Background Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease
causing severe locomotor disability and deterioration in the quality of life. Existing treatments …
causing severe locomotor disability and deterioration in the quality of life. Existing treatments …
[HTML][HTML] Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model
S Wang, Y Li, J Zhao, J Zhang, Y Huang - Biology of Blood and Marrow …, 2013 - Elsevier
Mesenchymal stem cells (MSC) attenuate albuminuria and preserve normal renal histology
in diabetic mice. However, the effects of MSC on glomerular podocyte injury remain …
in diabetic mice. However, the effects of MSC on glomerular podocyte injury remain …